EGFR and lung carcinoma: In a human lung cancer cell line that does not harbor either KRAS or EGFR mutations, i.e. NCI-H1437 (TP53R267P), intriguingly, TTF-1 did not significantly alter its cisplatin sensitivity (Fig. S4C,D).